Texas Permanent School Fund decreased its position in shares of Envision Healthcare Corp (NYSE:EVHC) by 8.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,192 shares of the company’s stock after selling 2,367 shares during the period. Texas Permanent School Fund’s holdings in Envision Healthcare were worth $1,243,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the stock. LPL Financial LLC raised its holdings in Envision Healthcare by 5.4% during the first quarter. LPL Financial LLC now owns 25,123 shares of the company’s stock worth $965,000 after purchasing an additional 1,298 shares in the last quarter. Savant Capital LLC increased its holdings in shares of Envision Healthcare by 42.3% in the second quarter. Savant Capital LLC now owns 7,699 shares of the company’s stock valued at $339,000 after buying an additional 2,290 shares in the last quarter. Zeke Capital Advisors LLC increased its holdings in shares of Envision Healthcare by 51.2% in the second quarter. Zeke Capital Advisors LLC now owns 9,014 shares of the company’s stock valued at $397,000 after buying an additional 3,051 shares in the last quarter. Contravisory Investment Management Inc. increased its holdings in shares of Envision Healthcare by 41.5% in the third quarter. Contravisory Investment Management Inc. now owns 10,606 shares of the company’s stock valued at $485,000 after buying an additional 3,111 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its holdings in shares of Envision Healthcare by 13.0% in the second quarter. State of Alaska Department of Revenue now owns 30,105 shares of the company’s stock valued at $1,323,000 after buying an additional 3,460 shares in the last quarter.
NYSE EVHC opened at $45.99 on Friday. Envision Healthcare Corp has a 1 year low of $23.77 and a 1 year high of $46.00.
Several research firms have issued reports on EVHC. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $46.00 price target on shares of Envision Healthcare in a report on Friday, August 10th. ValuEngine raised Envision Healthcare from a “strong sell” rating to a “sell” rating in a report on Monday, September 17th. Finally, Zacks Investment Research raised Envision Healthcare from a “hold” rating to a “buy” rating and set a $51.00 price target on the stock in a report on Friday, September 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company’s stock. Envision Healthcare has a consensus rating of “Hold” and an average target price of $44.12.
TRADEMARK VIOLATION NOTICE: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/11/10/envision-healthcare-corp-evhc-position-reduced-by-texas-permanent-school-fund.html.
Envision Healthcare Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Read More: Bear Market – How and Why They Occur
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corp (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.